We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$2.7B
1-Year Est. Return
29.67%
This Fund
S&P 500
This Quarter
Est. Return
-13.93%
1 Year Est. Return
+29.67%
3 Year Est. Return
+102.72%
5 Year Est. Return
+136.36%
10 Year Est. Return
+453.01%
AUM
$1.44B
AUM Growth
-$266M
(-16%)
Cap. Flow
-$4.59M
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
33.34%
Holding
325
New
10
Increased
75
Reduced
47
Closed
24
Top Buys
| 1 |
Burlington
BURL
|
+$598K |
| 2 |
Teleflex
TFX
|
+$547K |
| 3 |
GoDaddy
GDDY
|
+$471K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$452K |
| 5 |
Xometry
XMTR
|
+$416K |
Top Sells
| 1 |
Dentsply Sirona
XRAY
|
+$999K |
| 2 |
Citigroup
C
|
+$675K |
| 3 |
W.R. Berkley
WRB
|
+$655K |
| 4 |
Carlisle Companies
CSL
|
+$506K |
| 5 |
WillScot Mobile Mini Holdings
WSC
|
+$502K |
Sector Composition
| 1 | Technology | 24.14% |
| 2 | Industrials | 16.41% |
| 3 | Healthcare | 12.77% |
| 4 | Financials | 11.75% |
| 5 | Communication Services | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Burford Capital
BUR
$894M
| $293K | 0.02% |
28,994
| – | – |
|
227
Hamilton Lane
HLNE
$3.6B
| $291K | 0.02% |
4,337
+1,144
| +36% | +$78.8K |
|
228
CONMED
CNMD
$1.26B
| $289K | 0.02% |
3,023
| – | – |
|
229
Ligand Pharmaceuticals
LGND
$6.03B
| $288K | 0.02% |
5,171
| – | – |
|
230
Malibu Boats
MBUU
$524M
| $287K | 0.02% |
5,448
| – | – |
|
231
MaxLinear
MXL
$8.29B
| $286K | 0.02% |
8,421
| – | – |
|
232
Capital One
COF
$126B
| $281K | 0.02% |
2,695
+252
| +10% | +$30.8K |
|
233
Inspire Medical Systems
INSP
$1.42B
| $281K | 0.02% |
1,537
| – | – |
|
234
Canadian Pacific Kansas City
CP
$81.1B
| $278K | 0.02% |
3,977
| – | – |
|
235
Semtech
SMTC
$13.2B
| $276K | 0.02% |
5,023
+912
| +22% | +$55K |
|
236
Ameresco
AMRC
$1.32B
| $275K | 0.02% |
6,037
| – | – |
|
237
Kaiser Aluminum
KALU
$2.63B
| $273K | 0.02% |
3,451
| – | – |
|
238
Taylor Morrison
TMHC
$6.62B
| $273K | 0.02% |
11,680
| – | – |
|
239
NorthWestern Energy
NWE
$4.48B
| $273K | 0.02% |
4,627
| – | – |
|
240
Independent Bank
INDB
$4.06B
| $272K | 0.02% |
3,430
| – | – |
|
241
Parker-Hannifin
PH
$122B
| $272K | 0.02% |
1,104
| – | – |
|
242
Ultragenyx Pharmaceutical
RARE
$3.15B
| $269K | 0.02% |
4,512
+628
| +16% | +$38.6K |
|
243
Varonis Systems
VRNS
$5.53B
| $269K | 0.02% |
9,175
+3,447
| +60% | +$128K |
|
244
Valley National Bancorp
VLY
$8.08B
| $263K | 0.02% |
25,219
| – | – |
|
245
CAE Inc
CAE
$8.01B
| $260K | 0.02% |
10,556
| – | – |
|
246
Zoetis
ZTS
$31.1B
| $260K | 0.02% |
1,510
-464
| -24% | -$80.2K |
|
247
Marvell Technology
MRVL
$200B
| $259K | 0.02% |
5,948
-957
| -14% | -$54.2K |
|
248
Supernus Pharmaceuticals
SUPN
$2.71B
| $258K | 0.02% |
8,921
| – | – |
|
|
NUVA
249
DELISTED
NuVasive, Inc.
NUVA
| $258K | 0.02% |
5,247
| – | – |
|
|
ABB
250
DELISTED
ABB Ltd
ABB
| $257K | 0.02% |
9,632
-1,067
| -10% | -$31.7K |
|
Similar funds
TPSF
CI
GIA
PCM
SFS
HCM
NB
WGI